Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family

Human Molecular Genetics

Volumn 6, Issue 9, 1997, Pages 1513-1517

  Swensen, Jeff ^a   Hoffman, Michael ^a   Skolnick, Mark H ^a,b   Neuhausen, Susan L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Myriad Genetics Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADULT; ALU SEQUENCE; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CROSSING OVER; DELETION MUTANT; DNA POLYMORPHISM; DNA SEQUENCE; FAMILIAL CANCER; GENE; GENE MUTATION; HAPLOTYPE; HUMAN; HUMAN CELL; INTRON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

ADULT; BLOTTING, SOUTHERN; BRCA1 PROTEIN; BREAST NEOPLASMS; CROSSING OVER, GENETIC; DNA PRIMERS; DNA PROBES; FEMALE; GENES, TUMOR SUPPRESSOR; HAPLOTYPES; HUMANS; INTRONS; MIDDLE AGED; MUTATION; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); REPETITIVE SEQUENCES, NUCLEIC ACID; RESTRICTION MAPPING; SEQUENCE DELETION;

EID: 0030869406     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/6.9.1513     Document Type: Article

References (16)

1. Szabo, C.I. and King, M.C. (1995) Inherited breast and ovarian cancer. Hum. Mol. Genet. 4, 1811-1817.
2. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L.M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Mattier, T., Phelps, R., Haugen Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P.K., Norris, F.H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J.C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A. and Skolnick, M.H. (1994) Isolation of a strong candidate for the 17q-linked breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71.
3. Gayther S.A., Warren, W., Mazoyer, S., Russell, P.A., Harrington, P.A., Chiano, M., Seal, S., Hamoudi, R., van Rensburg, E., Dunning, A.M., Love, R., Evans, G., Easton, D., Clayton, D., Stratton, M.R. and Ponder, B.A.J. (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nature Genet. 11, 428-433.
4. Serova O., Montagna, M., Torchard, D., Narod, S.A., Tonin, P., Sylla, B., Lynch, H.T., Feunteun, J. and Lenoir, G.M. (1996) A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am. J. Hum. Genet. 58, 42-41.
5. Ariga, T., Carter, P.E. and Davis III, A.E. (1990) Recombinations between Alu repeat sequences that result in partial deletions within the C1 inhibitor gene. Genomics 8, 607-613.
6. Huang, L.-S., Ripps, M.E., Korman, S.H., Deckelbaum, R.J. and Breslow, J.L. (1989) Hypobetalipoproteinemia due to an apolipoprotein B gene exon 21 deletion derived by Alu-Alu recombination. J. Biol. Chem. 264, 11394-11400.
7. Neote, K., Mclnnes, B., Mahuran, D.J. and Gravel, R.A. (1990) Structure and distribution of an Alu-type deletion mutation in Sandhoff disease. J. Clin. Invest. 86, 1524-1531.
8. Nyström-Lahti, M., Kristo, P., Nicolaides, N.C., Chang, S.Y., Aaltonen, L.A., Moisio, A.L., Järvinen, H.J., Mecklin, J.-P., Kinzler, K.W., Vogelstein, B., de la Chapelle, A. and Peltomäki, P. (1995) Founding mutations and Alu mediated recombination in hereditary colon cancer. Nature Med. 1, 1203-1206.
9. Mauillon, J.L., Michel, P., Limacher, J.-M., Latouche, J.-B., Dechelotte, P., Charbonnier, F., Martin, C., Moreau, V., Metayer, J., Paillot, B. and Frebourg, T. (1996) Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancer. Cancer Res. 56, 5728-5733.
10. Puget, N., Torchard, D., Serova-Sinilnikova, O.M., Lynch, H.T., Feunteun, J., Lenoir, G.M. and Mazoyer, S. (1997) A 1 kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res. 57, 828-831.
11. Xu, C.-F., Brown, M.A., Chambers, J.A., Griffiths, B., Nicolai, H. and Solomon, E. (1995) Distinct transcription start sites generate two forms of BRCA1 mRNA. Hum. Mol. Genet. 4, 2259-2264.
12. Neuhausen, S.L., Swensen, J., Miki, Y., Liu, Q., Tavtigian, S., Shattuck-Eidens, D., Kamb, A., Hobbs, M.R., Gingrich, J., Shizuya, H., Kim, U.-J., Cochran, C., Futreal, P.A., Wiseman, R.W., Lynch, H.T., Tonin, P., Narod, S., Cannon-Albright, L., Skolnick, M.H., and Goldgar, D.E. (1994) A P1-based physical map of the region from D17S776 to D17S78 containing the breast cancer susceptibility gene BRCA1. Hum. Mol. Genet. 3, 1919-1926.
13. Smith, T.M., Lee, M.K., Szabo, C.I., Jerome, N., McEuen, M., Taylor, M., Hood, L. and King, M.-C. (1996) Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res. 6, 1029-1049.
14. Brown, M.A., Xu, C.F., Nicolai, H., Griffiths, B., Chambers, J.A., Black, D. and Solomon, E. (1996) The 5′ end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogene 12, 2507-2513.
15. Ford, D., Easton, D.F., Bishop, D.T., Narod, S.A., Goldgar, D.E. and the Breast Cancer Linkage Consortium (1994) Risks of cancer in BRCA1 mutation carriers. Lancet 343, 692-695.
16. Swensen, J. (1996) PCR with random primers to obtain sequence from yeast artificial chromosome insert ends or plasmids. BioTechniques 20, 486-491.